| Literature DB >> 34642391 |
Leonia Hiu Wan Lau1, Ngai Sze Wong2, Chi Chiu Leung3, Chi Kuen Chan4, Alexis K H Lau5,6, Linwei Tian7, Shui Shan Lee8.
Abstract
Summer-spring predominance of tuberculosis (TB) has been widely reported. The relative contributions of exogenous recent infection versus endogenous reactivation to such seasonality remains poorly understood. Monthly TB notifications data between 2005 and 2017 in Hong Kong involving 64,386 cases (41% aged ≥ 65; male-to-female ratio 1.74:1) were examined for the timing, amplitude, and predictability of variation of seasonality. The observed seasonal variabilities were correlated with demographics and clinical presentations, using wavelet analysis coupled with dynamic generalised linear regression models. Overall, TB notifications peaked annually in June and July. No significant annual seasonality was demonstrated for children aged ≤ 14 irrespective of gender. The strongest seasonality was detected in the elderly (≥ 65) among males, while seasonal pattern was more prominent in the middle-aged (45-64) and adults (30-44) among females. The stronger TB seasonality among older adults in Hong Kong suggested that the pattern has been contributed largely by reactivation diseases precipitated by defective immunity whereas seasonal variation of recent infection was uncommon.Entities:
Mesh:
Year: 2021 PMID: 34642391 PMCID: PMC8511215 DOI: 10.1038/s41598-021-99651-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Tuberculosis incidence in the Asia–Pacific region, 2017 (per 100,000 population). We downloaded the country boundaries from GADM database (https://gadm.org/data.html), and the global TB incidence data from world Health Organization (https://www.who.int/data/gho/data/themes/tuberculosis) for the generation of this figure.
Profile (socio-demographic and clinical) of notified TB cases in Hong Kong by age, gender, and disease form, 2005–2017.
| Male, n = 40,908; no. (%) | Female, n = 23,478; no. (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Pulmonary TBa | Extrapulmonary TB | Pulmonary TBa | Extrapulmonary TB | |||||
| Aged ≥ 65 | Aged < 65 | Aged ≥ 65 | Aged < 65 | Aged ≥ 65 | Aged < 65 | Aged ≥ 65 | Aged < 65 | |
| Total no. of TB notifications | 17,619 | 19,222 | 1666 | 2401 | 5765 | 12,061 | 1338 | 4314 |
| Hong Kong | 3207 (19.0) | 10,835 (58.6) | 318 (19.8) | 1472 (63.1) | 1092 (19.8) | 5643 (48.6) | 311 (23.80) | 1848 (43.8) |
| Mainland China and Macau | 13,290 (78.8) | 6900 (37.3) | 1227 (76.3) | 674 (28.9) | 4263 (77.4) | 3585 (30.9) | 933 (71.5) | 1229 (29.2) |
| Other key Asian countriesb | 241 (1.4) | 594 (3.2) | 44 (2.7) | 154 (6.6) | 111 (2.0) | 2292 (19.7) | 44 (3.4) | 1114 (26.4) |
| Miscellaneous | 125 (0.7) | 160 (0.9) | 20 (1.2) | 33 (1.4) | 44 (0.8) | 98 (0.8) | 17 (1.3) | 24 (0.6) |
| Yes | 17,370 (99.7) | 18,469 (97.1) | 1629 (99.5) | 2271 (96.4) | 5666 (99.5) | 9449 (79.1) | 1309 (99.6) | 3201 (75.6) |
| No | 48 (0.3) | 546 (2.9) | 8 (0.5) | 85 (3.6) | 30 (0.5) | 2497 (20.9) | 5 (0.4) | 1034 (24.4) |
| Full time employment | 629 (3.6) | 10,259 (53.9) | 77 (4.7) | 1367 (57.8) | 52 (0.9) | 6265 (52.3) | 25 (1.9) | 2345 (54.9) |
| Students | 3 (0.02) | 1121 (5.90 | 1 (0.1) | 163 (6.9) | 2 (0.03) | 970 (8.1) | 1 (0.1) | 178 (4.2) |
| Homemaker | 18 (0.1) | 4 (0.02) | 4 (0.2) | 3 (0.1) | 3892 (68.1) | 2977 (24.9) | 796 (60.6) | 1176 (27.5) |
| Retired/unemployed | 16,496 (94.4) | 6781 (35.6) | 1522 (92.6) | 739 (31.2) | 1622 (28.4) | 1273 (10.6) | 469 (35.7) | 451 (10.6) |
| Others | 337 (1.9) | 886 (4.7) | 40 (2.4) | 93 (3.9) | 148 (2.6) | 491 (4.1) | 23 (1.8) | 122 (2.9) |
| New cases | 14,711 (84.0) | 17,304 (90.5) | 1493 (91.1) | 2207 (93.0) | 5200 (90.9) | 11,364 (94.7) | 1252 (94.8) | 4013 (93.8) |
| Previous infected OR treated cases | 2792 (16.0) | 1824 (9.5) | 146 (8.9) | 167 (7.0) | 523 (9.1) | 635 (5.3) | 69 (5.2) | 263 (6.2) |
| Smear positive | 6105 (36.3) | 7706 (42.2) | 0 (0) | 0 (0) | 1700 (31.8) | 4237 (37.4) | 0 (0) | 0 (0) |
| Smear negative | 10,717 (63.7) | 10,551 (57.8) | 1029 (100.0) | 1599 (100.0) | 3639 (68.2) | 7090 (62.6) | 723 (100.0) | 2854 (100.0) |
| Culture positive | 13,588 (84.2) | 13,075 (74.6) | 0 (0) | 0 (0) | 4131 (80.6) | 7590 (70.1) | 0 (0) | 0 (0) |
| Culture negative | 2557 (15.8) | 4459 (25.4) | 847 (100) | 1395 (100) | 993 (19.4) | 3239 (29.9) | 621 (100) | 2560 (100) |
| Drug resistance | 53 (0.4) | 154 (1.2) | 0 (0) | 0 (0) | 8 (0.2) | 86 (1.1) | 0 (0) | 0 (0) |
| Presence of any co-morbid condition | 7051 (40.0) | 4486 (23.3) | 695 (41.7) | 399 (16.6) | 2157 (37.4) | 1483 (12.3) | 509 (38.0) | 1347 (31.2) |
| Diabetes mellitus | 3048 (17.3) | 2831 (14.7) | 299 (17.9) | 170 (7.1) | 1050 (18.2) | 736 (6.1) | 217 (16.2) | 147 (3.4) |
| Lung cancer | 539 (3.1) | 229 (1.2) | 26 (1.6) | 16 (0.7) | 108 (1.9) | 68 (0.6) | 16 (1.2) | 14 (0.3) |
| Other malignancies | 1117 (6.3) | 631 (3.3) | 151 (9.1) | 91 (3.8) | 280 (4.9) | 221 (1.8) | 135 (10.1) | 133 (3.1) |
| Chronic renal failure | 258 (1.5) | 151 (0.8) | 74 (4.4) | 54 (2.2) | 75 (1.3) | 59 (0.5) | 49 (3.7) | 53 (1.2) |
| HIV infection | 33 (0.2) | 199 (1.0) | 5 (0.3) | 40 (1.7) | 3 (0.1) | 49 (0.4) | 0 (0.0) | 13 (0.3) |
| Silicosis and other pneumoconiosis (e.g., asbestosis) | 155 (0.9) | 130 (0.7) | 11 (0.7) | 7 (0.3) | 2 (0.03) | 2 (0.02) | 0 (0.0) | 1 (0.02) |
| Others chronic respiratory diseasee | 1441 (8.2) | 327 (1.7) | 70 (4.2) | 20 (0.8) | 242 (4.2) | 135 (1.1) | 20 (1.5) | 19 (0.4) |
| Gastrectomy | 114 (0.6) | 32 (0.2) | 17 (1.0) | 1 (0.04) | 20 (0.3) | 3 (0.02) | 3 (0.2) | 2 (0.05) |
| General debilitation (due to old age, immobility, stroke) | 1966 (11.2) | 77 (0.4) | 214 (12.8) | 6 (0.2) | 762 (13.2) | 26 (0.2) | 162 (12.1) | 13 (0.3) |
| Autoimmune diseasef | 113 (0.6) | 138 (0.7) | 21 (1.3) | 24 (1.0) | 69 (1.2) | 193 (1.6) | 28 (2.1) | 64 (1.5) |
| Received organ transplantation | 8 (0.05) | 27 (0.1) | 0 (0.0) | 10 (0.4) | 1 (0.02) | 26 (0.2) | 0 (0.0) | 3 (0.1) |
| Liver diseaseg | 76 (0.4) | 78 (0.4) | 9 (0.5) | 12 (0.5) | 14 (0.2) | 19 (0.2) | 6 (0.4) | 6 (0.1) |
| On cytotoxic/steroid/biologics or other immunosuppressant | 165 (0.9) | 180 (0.9) | 20 (1.2) | 39 (1.6) | 79 (1.4) | 235 (1.9) | 24 (1.8) | 54 (1.3) |
aPatients classified as pulmonary TB may include extrapulmonary TB.
bIncluding Philippines, Indonesia, Thailand, Nepal, Vietnam, India, Pakistan, and Bangladesh.
c7 years of stay in Hong Kong required for permanent residency, except by birth.
dResistance to at least one first line antituberculosis agent.
eIncluding chronic obstructive pulmonary disease (COPD); bronchiectasis; asthma; interstitial lung disease.
fIncluding systemic lupus erythematosus; Sjogren’s syndrome; multiple sclerosis; myasthenia gravis; Guillain–Barre Syndrome; ankylosing spondylitis; rheumatoid arthritis; psoriatic arthritis. Grave’s disease; Addison’s disease; Hashimoto’s thyroiditis; ulcerative colitis; Crohn’s disease, primary biliary cirrhosis; celiac disease; psoriasis; autoimmune blistering disease (e.g., pemphigus; pemphigoid; Ig-mediated bullous dermatoses); autoimmune encephalitis (e.g., acute disseminated encephalomyelitis); sarcoidosis; vitiligo; antiphospholipid; pernicious anaemia; aplastic anaemia; idiopathic thrombocytopenia purpura; autoimmune vasculitis (e.g., Behcet's syndrome; Giant cell arteritis; Churg-Strauss syndrome; Takayasu’s arteritis; polymyalgia rheumatic); Glomerulonephritis; IgA nephropathy; Goodpasture’s syndrome; Wegener’s granulomatosis; scleroderma; polymyositis; dermatomyositis.
gIncluding fatty liver; liver cirrhosis; liver fibrosis.
Figure 2Wavelet analysis of monthly notification of elderly (≥ 65) TB in Hong Kong from 2005–2017, for (a) males’ all forms TB cases; (b) females’ all forms TB cases; (c) males’ pulmonary TB cases; (d) females’ pulmonary TB cases; (e) males; extrapulmonary TB cases; and (f) females’ extrapulmonary TB cases. (Right) Global wavelet power spectrum: thick black lines represent the global wavelet power estimates and the grey band indicate the 95% confidence bounds against red-noise background spectra. Significant annual periodicity is indicated when the peak of power exceeds the grey band at 1-year period. (Left) Local wavelet power spectrum: Wavelet power value is shown in colour from dark blue (low value) to dark red (high value). Area enclosed with black contour lines indicates the 5% significance level against red noise. Lighter shade area indicates the cone of influence where the edge effect becomes important, and the spectral information is less robust.
Seasonality of all forms of tuberculosis by gender and age.
| Age group | Gender | Continuous wavelet transform (CWT)a | Dynamic generalised linear regression (DGLMs) | ||||
|---|---|---|---|---|---|---|---|
| Global power spectrum: (i.e., presence of dominant annual periodicity) | Local power spectrum: (predictability of seasonal variation: time evolution of annual periodicity) | Seasonal amplitude (peak-to-tough ratio) | Peak timing in year (months) | ||||
| Maximum (95% CI) | Minimum (95% CI) | Maximum (95% CI) | Minimum (95% CI) | ||||
| Elderly (≥ 65) | Male | Annual seasonality | Strongly evident from 2005–2012 | 1.24 (1.15–1.30) | 1.14 (1.13–1.23) | 6.53 (5.96–6.79) | 6.32 (5.88–6.76) |
| Weaker and non-significant after 2012 | |||||||
| Female | Annual seasonality | Strongly evident from 2005–2006; 2008–2012 | 1.25 (1.16–1.33) | 1.25 (1.17–1.35) | 7.40 (6.97–7.99) | 7.40 (6.94–8.00) | |
| Weaker and non-significant after 2012 | |||||||
| Middle aged (45–64) | Male | Annual seasonality | Strongly evident in 2005–2008 and 2012 | 1.16 (1.09–1.27) | 1.16 (1.08–1.25) | 6.67 (6.14–7.69) | 6.67 (5.81–7.39) |
| Weaker, non-significant in other time periods | |||||||
| Female | Annual seasonality | Strongly evident from 2005 and 2008–2014 | 1.30 (1.23–1.40) | 1.30 (1.23–1.40) | 7.24 (6.87–7.64) | 7.24 (6.87–7.66) | |
| Weaker and non-significant after 2014 | |||||||
| Adults (30–44) | Male | No significant seasonality | – | – | – | – | – |
| Female | Annual seasonality | Strongly evident in 2005–2013 | 1.29 (1.22–1.37) | 1.29 (1.22–1.37) | 6.58 (6.16–6.89) | 6.57 (6.16–6.89) | |
| Weaker and non-significant after 2013 | |||||||
| Young adults (15–29) | Male | Annual seasonality | Strongly evident in 2005–2007; 2010–2013 | 1.20 (1.12–1.31) | 1.20 (1.13–1.32) | 7.13 (6.31–7.92) | 7.13 (6.01–7.91) |
| Weaker, non-significant in other time periods | |||||||
| Female | Annual seasonality | Strongly evident in 2005–2007 | 1.28 (1.17–1.38) | 1.28 (1.17–1.39) | 6.83 (6.23–7.44) | 6.83 (6.25–7.44) | |
| Weaker, non-significant in other time periods | |||||||
| Children (0–14) | Male | No significant seasonality | – | – | – | – | – |
| Female | No significant seasonality | – | – | – | – | – | |
aStatistical significance of computed wavelet power spectrum was tested against the red noise background representing the null hypothesis that the observed time-series is no different to that expected from a purely random process, with significance level of 95%.
Seasonality of pulmonary (PTB) and extrapulmonary tuberculosis (EPTB) by gender and age.
| Age group | Gender | Pulmonary Tuberculosis | Extrapulmonary Tuberculosis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Continuous wavelet transform (power spectrum) | Dynamic generalised linear regression | Continuous wavelet transform (power spectrum) | Dynamic generalised linear regression | ||||||||||
| Globala | Localb | Seasonal amplitude (peak-to-tough ratio) | Peak timing in year (months) | Globala | Localb | Seasonal amplitude (peak-to-tough ratio) | Peak timing (months) | ||||||
| Elderly (≥ 65) | Male | * | 2005–2012 | 1.22 (1.13–1.33) | 1.16 (1.12–1.24) | 6.42 (5.96–6.82) | 6.31 (5.85–6.80) | – | – | – | – | – | – |
| Female | – | – | – | – | – | – | * | 2009–2012; & 2014–2017 | 1.64 (1.50–2.22) | 1.64 (1.45–1.91) | 7.56 (7.11–8.09) | 7.56 (6.97–8.01) | |
| Middle aged (45–64) | Male | * | 2005–2008; & 2012 | 1.16 (1.08–1.28) | 1.16 (1.08–1.24) | 6.65 (5.94–7.56) | 6.65 (5.84–7.35) | * | 2013–2015 | 1.33 (1.07–1.52) | 1.22 (1.10–1.67) | 7.52 (5.01–8.20) | 5.44 (5.06–8.11) |
| Female | * | 2005–2013 | 1.33 (1.27–1.58) | 1.33 (1.24–1.48) | 7.50 (6.93–8.11) | 7.49 (7.01–8.06) | * | 2012–2015 | 1.28 (1.17–1.44) | 1.28 (1.18–1.45) | 6.60 (5.87–7.33) | 6.60 (5.90–7.33) | |
| Adult (30–44) | Male | – | – | – | – | – | – | – | – | – | – | – | – |
| Female | * | 2005–2007; &2011–2014 | 1.29 (1.20–1.40) | 1.29 (1.20–1.39) | 6.91 (6.33–7.37) | 6.91 (6.34–7.36) | * | 2005–2008 | 1.93 (1.13–2.10) | 1.24 (1.09–1.59) | 7.03 (4.17–7.13) | 4.39 (3.93–7.66) | |
| Youngadults (15–29) | Male | * | 2005–2006; and 2013 | 1.18 (1.10–1.29) | 1.18 (1.10–1.30) | 7.14 (6.22–7.89) | 7.14 (6.15–7.93) | * | 2007–2008; and 2010–2013 | 1.48 (1.25–1.90) | 1.22 (1.18–1.90) | 8.14 (5.98–8.41) | 5.79 (4.75–8.11) |
| Female | * | 2005–2007 | 1.28 (1.16–1.38) | 1.28 (1.16–1.38) | 7.13 (6.43–7.74) | 7.13 (6.45–7.74) | * | 2005; 2009 | 1.39 (1.16–1.72) | 1.34 (1.15–1.69) | 5.82 (4.75–6.90) | 5.80 (4.62–7.00) | |
| Children (0–14) | Male | – | – | – | – | – | – | – | – | – | – | – | – |
| Female | – | – | – | – | – | – | – | – | – | – | – | – | |
aGlobal wavelet power spectrums determined the existence of a dominating and significant annual periodicity overall through the time series.
bLocal wavelet power spectrums showed the time evolution of annual periodic components and predictability of the seasonal variation.
*Indicated presence of significant annual seasonality.